Reports From the Field

COVID-19 Screening and Testing Among Patients With Neurologic Dysfunction: The Neuro-COVID-19 Time-out Process and Checklist


 

References

The Protected Code Stroke pathway offers protection in the emergent setting for patients with stroke when their COVID-19 status is unknown.3 A similar process has been applied at our institution for emergent management of patients with cerebrovascular disease (stroke, intracerebral hemorrhage, and subarachnoid hemorrhage). However, the process from the ED after designating “difficult to screen” patients as persons under investigation (PUI) is unclear. The Centers for Disease Control and Prevention (CDC) has delineated the priorities for testing, with not all declared PUIs requiring testing.4 This poses a great challenge, because patients designated as PUIs require the same management as a COVID-19-positive patient, with negative-pressure isolation rooms as well as use of protective personal equipment (PPE), which may not be readily available. It was also recognized that, because the ED staff can be overwhelmed by COVID-19 patients, there may not be enough time to perform detailed screening of patients with neurologic dysfunction and that “reverse masking” may not be done consistently for nonintubated patients. This may place patients and health care workers at risk of unprotected exposure.

Recognizing these challenges, we created a Neuro-COVID-19 Time-out Process and Checklist (NCOT-PC) as a quality improvement project. The aim of this project was to improve and standardize the current process of identifying patients with neurologic dysfunction who require COVID-19 testing to decrease the risk of unprotected exposure of patients and health care workers.

Methods

Patients and Definitions

This quality improvement project was undertaken at the University of Mississippi Medical Center NSICU. Because this was a quality improvement project, an Institutional Review Board exemption was granted.

The NCOT-PC was utilized in consecutive patients with neurologic dysfunction admitted to the NSICU during a period of 1 week. “Neurologic dysfunction” encompasses any neurologic illness affecting the mental status and/or level of alertness, subsequently precluding the ability to reliably screen the patient utilizing standard COVID-19 screening. “Med-Com” at our institution is the equivalent of the national COVID-19 testing hotline, where our institution’s infectious diseases experts screen calls for testing and determine whether testing is warranted. “Unprotected exposure” means exposure to COVID-19 without adequate and appropriate PPE.

Quality Improvement Process

As more PUIs were being admitted to the institution, we used the Plan-Do-Study-Act method for process improvements in the NSICU.5 NSICU stakeholders, including attendings, the nurse manager, and nurse practitioners (NPs), developed an algorithm to facilitate the coordination of the NSICU staff in screening patients to identify those with a high likelihood of needing COVID-19 testing upon arrival in the NSICU (Figure 1). Once the NCOT-PC was finalized, NSICU stakeholders were educated regarding the use of this screening tool.

 Neuro-COVID-19 Time-out Process algorithm in the neuroscience intensive care unit (NSICU)

Pages

Recommended Reading

COVID-19 and the psychological side effects of PPE
Journal of Clinical Outcomes Management
Dr. Fauci: ‘About 40%-45% of infections are asymptomatic’
Journal of Clinical Outcomes Management
2020-2021 respiratory viral season: Onset, presentations, and testing likely to differ in pandemic
Journal of Clinical Outcomes Management
Many Americans still concerned about access to health care
Journal of Clinical Outcomes Management
Low vitamin D in COVID-19 predicts ICU admission, poor survival
Journal of Clinical Outcomes Management
Survey quantifies COVID-19’s impact on oncology
Journal of Clinical Outcomes Management
Observational study again suggests lasting impact of COVID-19 on heart
Journal of Clinical Outcomes Management
CDC adds then retracts aerosols as main COVID-19 mode of transmission
Journal of Clinical Outcomes Management
Systemic Corticosteroids in Critically Ill Patients With COVID-19
Journal of Clinical Outcomes Management
“I Really Didn’t Want To Come In”: The Unseen Effects of COVID-19 on Children
Journal of Clinical Outcomes Management